Figure 3From: An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration Amikacin serum concentration time data for Patient P5. The shaded areas indicate the target therapeutic peak and trough ranges.Back to article page